Skip to content

Posts

January 2023 Update

SOP Updates

  • New! Non-Industry Fee Schedule / Site Budget Guidance created.
  • Updated! UUSOP-14: Safety Assessment and Reporting has been updated
  • Updated! UUSOP-13: Institutional Fee Schedule and UUSOP-13-A: Fee Schedule Cost Rationale have been updated

Share this article:

May 2022 Update

SOP Updates

  • Updated! UUSOP-13: Institutional Fee Schedule (for Industry-Sponsored research)
  • Updated!UUSOP-13-A: Fee Schedule Cost Rationale updated to describe the services and activities supported by the CTMS/OnCore fee.
  • New! UUSOP-14: Clinical Trial Safety Assessment and Reporting

Share this article:

December 2021 Update

SOP Updates

  • New! UUSOP-13 (Institutional Fee Schedule) released
  • New! UUSOP-14 (Safety Assessment and Reporting) released
  • UUSOP-01 (SOP Process) updated with guidance regarding the relationship and differences between SOPs and guidance and/or work practice documents (WPD)

Share this article:

July 2021 Update

SOP Updates

  • USOP-04 (Investigator Responsibilities) updated with guidance on master Adverse Events (AE) and Deviation logs
  • UUSOP-05 (Delegation of Authority) updated to include guidance for key personnel role changes
  • UUSOP-08 (Informed Consent) updated with guidance for documenting informed consent in the participant’s medical record
  • New! UUSOP-11 (Investigational New Drug Application in FDA-Regulated Research) released
  • New! UUSOP-12 (Investigational Device Exemption Applications in FDA-Regulated Research) released

Share this article:
Last Updated: 12/13/23